Details for Patent: 11,084,809
✉ Email this page to a colleague
Which drugs does patent 11,084,809 protect, and when does it expire?
Patent 11,084,809 protects EKTERLY and is included in one NDA.
This patent has ninety-six patent family members in forty-two countries.
Summary for Patent: 11,084,809
| Title: | N-((HET)arylmethyl)-heteroaryl-carboxamides compounds as kallikrein inhibitors |
| Abstract: | The present invention provides compounds of formula (I):compositions comprising such compounds; the use of such compounds in therapy (for example in the treatment or prevention of a disease or condition in which plasma kallikrein activity is implicated); and methods of treating patients with such compounds; wherein R5, R6, R7, A, B, W, X, Y and Z are as defined herein. |
| Inventor(s): | Rebecca Louise Davie, Hannah Joy Edwards, David Michael Evans, Simon Teanby Hodgson |
| Assignee: | Kalvista Pharmaceuticals Ltd , Dri Uk Lp |
| Application Number: | US16/944,658 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,084,809
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Kalvista | EKTERLY | sebetralstat | TABLET;ORAL | 219301-001 | Jul 3, 2025 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | Y | TREATMENT OF ACUTE ATTACKS OF HEREDITARY ANGIOEDEMA (HAE) IN ADULTS AND PEDIATRIC PATIENTS 12 YEARS OF AGE AND OLDER | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,084,809
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 3224256 | ⤷ Start Trial | C20265004 | Finland | ⤷ Start Trial |
| European Patent Office | 3224256 | ⤷ Start Trial | PA2026502 | Lithuania | ⤷ Start Trial |
| European Patent Office | 3224256 | ⤷ Start Trial | 301364 | Netherlands | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
